[1]
Aslonov I.F. 2026. IMPACT OF COMORBID CONDITIONS ON THE DEVELOPMENT OF NEPHROTOXICITY IN PATIENTS RECEIVING ANTI-TUBERCULOSIS THERAPY. Central Asian Journal of Medicine. 1, 11 (янв. 2026), 240–245.